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1. Case presentation
A 24-year-old man who belongs to military
services in Japan had an annual health check.
His ECG showed a relatively short QT interval
(QT interval is approximately less than 320ms)
despite having a slow heart rate of 56 beats per
minute (Figure 1). He is healthy and free from any
symptoms. His past history is not contributory and
his family history revealed no cases of sudden
cardiac death cases. What is the most important
diﬀerential diagnosis, when you see this type of
ECG?
2. Commentary
A website (www.shortqtsyndrome.org) was estab-
lished to disseminate the concept on a newly
discovered heart disease called Short QT Syndrome.
This Short QT Syndrome is easily overlooked and
sometimes relates with life-threatening arrhythmias.
Dr. Bjerregaard ﬁrst discovered this Short QT
Syndrome in 1999.1) Later research has contributed
to the current understanding of its hereditary
features, clinical manifestations, and treatment op-
tions. Short QT Syndrome is a relatively unknown
disease and a great number of physicians including
cardiologist are not aware of the condition.
Short QT Syndrome is a congenital disease
whose electrical activity in the heart is abnormal.
As reﬂected in the name, the ECG of these patients
show the duration of the QT interval at the heart
rate of around 60 beats per minute to be between
210 and 340ms, while the QT interval in normal
subjects is between 350 and 440ms. Another
important ﬁnding in Short QT Syndrome is that
the QT interval varies very little with changes in
Figure 1 A 24-year-old healthy subject’s
12-lead ECG recorded during an annual
health check
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the heart rate. In normal subjects, QT interval is
prolonged when the heart rate becomes slow
whereas patients with Short QT Syndrome show a
relatively constant QT interval regardless the heart
rate. These ﬁndings include no QT interval short-
ening according to the fast heart rates. This
phenomenon is not observed in normal subjects.
Although this abnormal ﬁnding seems minor, those
with Short QT Syndrome have proved to be
predisposed to lethal arrhythmias; it is relatively
easy to cause R on T phenomenon when ventricular
premature beats frequently occur.
The short QT interval observed in Short QT
Syndrome increases the risk of arrhythmias originat-
ing in either atrium or ventricle. Atrial ﬁbrillation
and ventricular ﬁbrillation are both of concern in
Short QT Syndrome.
The ﬁrst case presentation with familial Short QT
Syndrome
On February 16, 1999, a 17-year-old, healthy,
white female presented with cholelithiasis and
received laparoscopic cholecystectomy. At the end
of the procedure, atrial ﬁbrillation with fast ven-
tricular response was developed. The heart rate of
atrial ﬁbrillation is 150–200 beats per minute. She
subsequently developed acute pulmonary edema.
The DC cardioversion was successful and she was
discharged on digoxin in normal sinus rhythm. Six
weeks later, she suﬀered recurrence of artial
ﬁbrillation. She was referred to Dr. Bjerregaard
for further evaluation. He discovered that this
patient had a short QT interval (225ms). He asked
the patient’s close relatives to take the ECG
recordings. At the same time, Dr. Bjerregaard
initiated prophylactic therapy with propafenone.
Six months passed without any asymptomatic atrial
ﬁbrillation so the propafenone was discontinued.
Two months later atrial ﬁbrillation recurred, and
propafenone administration was re-instituted. For
more than four years she had been asymptomatic
on propafenone therapy without atrial ﬁbrillation.
On August 8, 2003, following reports from Italy
in which sudden cardiac death was observed in
patients with Short QT Syndrome,2) she underwent
an electrical physiological study with induction
of ventricular ﬁbrillation. Ventricular ﬁbrillation
was easily and reproducibly induced and she
received an implantable cardioverter deﬁbrillator
(ICD).
The ﬁrst report of a genetic mutation in Short QT
Syndrome
An association between Short QT Syndrome and
mutations in KCNH2 or the HERG gene was ﬁrst
reported in 2004.3) Three families were studied and
in two of them, two diﬀerent missense mutations
were revealed. This resulted in the same amino acid
change (N588K) in the S5-P loop region of the
IKr channel HERG (KCNH2) in the heart. The net
eﬀect of these mutations is to increase the repola-
rizing currents. This increase of the repolarizing
currents during the early phases of the action
potential leads to shorten the action potential and
thus to shorten the QT interval. The authors
speculate that the heterogeneous distribution of
abnormal ion currents exits within the heart in
Short QT Syndrome patients. It is possible that this
causes dispersion of repolarization and provides the
substrate for both atrial and ventricular arrhyth-
mias4) (Table 1).
The ﬁrst case with ICD implantation in Short QT
Syndrome
In the early phase of Short QT Syndrome treat-
ment attempts, inappropriate shock of ICD implant-
ed to Short QT Syndrome patients was problematic.
An ICD was ﬁrst implanted prophylactically in 5
Table 1 Mechanism behind arrhythmias in Short QT Syndrome
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members of two European families with Short QT
Syndrome. However, shortly after implantation 3 of
the patients complained of inappropriate shock due
to T wave oversensing.5) It was considered that the
detection of short-coupled and prominent T waves
in Short QT Syndrome patients is the trigger for
malfunction of ICDs.
The ﬁrst evaluation of pharmacological treat-
ment of Short QT Syndrome
Flecainide, sotalol, ibutilide and hydroquinidine
were reported to be eﬀective for prolonging the QT
interval to the normal range, and they also prevented
ventricular arrhythmias in 6 recently evaluated
patients with Short QT Syndrome.6) It revealed that
class IC and III antiarrhythmic drugs were not
eﬀective in signiﬁcantly increasing the QT interval,
whereas hydroquinidine prolonged the QT interval
from 263 12 to 362 25ms. Ventricular pro-
grammed stimulation only performed during hydro-
quinidine therapy showed increase of ventricular
refractory period to 200ms, and ventricular ﬁbril-
lation could not be inducible by hydroquinidine
therapy.
Clinical features and when to suspect Short QT
Syndrome7)
No strict criteria for diagnosing Short QT Syn-
drome have been presented (QT interval less than
300ms). Another characteristic ﬁnding in Short QT
Syndrome is a short ST-segment followed by tall and
narrow T waves in precordial leads as shown in
Figure 2. In addition, multiple inappropriate ICD
shocks due to T-wave oversensing and double
counting is frequent. Short QT Syndrome is sus-
pected in the following: 1) Lone atrial ﬁbrillation
especially at a young age, 2) Family member with
short QT interval, 3) Family member with sudden
cardiac death, 4) QT interval at 60 beats per minute
< 320ms or < 350ms, 350ms (2SD < mean pre-
dicted value) or 320ms (80% < mean predicted
value), 5) ECG with tall and peaked T waves
especially in precordial leads, 6) Lack of QT interval
prolongation with slowing of heart rate. If the
diagnosis is questionable from the standard ECG,
the next step is a 24-hour ambulatory ECG recording
(Holter monitoring). This is a continuous ECG
recording using a small portable recorder (tape or
digital technique) with 4–6 electrodes applied to the
front of the chest wall. Since the heart rate varies
over a 24 hour period, it gives the physician the
opportunity to measure the QT-interval at many
diﬀerent heart rates. The diagnosis can be made with
greatest certainty between 60 and 80 beats per
minute. The next step could be an electrophysio-
logic study, but the indication for such a study has
not been established yet. The diagnosis can be
ﬁrmly made in cases where one of the genetic
defects is found. How often this will be the case is
not known, but many patients have been found to
carry the gene abnormality associated with Short QT
Syndrome.
Figure 2 Precordial ECG recording strip in patient with
typical Short QT Syndrome
Table 2 Short QT Syndrome; Diagnostic criteria proposed
by Gollob MH et al (from Reference 8)
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Short QT Syndrome diagnostic criteria
Quite recently, ECG diagnostic criteria for Short
QT Syndrome have been proposed (Table 2).8) In
these criteria, high-probability Short QT Syndrome
is 4 points, intermediate-probability Short QT
Syndrome is 3 points, and low-probability Short
QT Syndrome is 2 points. ECG must be recorded
in the absence of modiﬁers known to shorten the QT.
J point-T peak interval must be measured in the
precordial lead with the greatest amplitude T-wave.
Regarding clinical history, events must occur in the
absence of an identiﬁable etiology, including struc-
tural heart disease. Cardiac arrest, documented
polymorphic ventricular tachycardia or unexplained
syncope are given 1 point. For family history, points
can only be received once. These Short QT Syn-
drome diagnostic criteria are based on a total of 61
cases identiﬁed and reported in English language
journals. In 35 out of 61 cases (57.4%) lethal events
included sudden cardiac death, aborted cardiac
arrest, syncope. This cohort consisted of predom-
inantly male (75.4%) and had a mean QTc values of
306.7ms ranging from 248 to 381ms.
3. Summary
Even if the prevalence of Short QT Syndrome
accompanying lethal arrhythmias is rare,9–12) it is
important that cardiologists keep this syndrome in
mind when caring for the non-structural heart disease
patients with syncope or aborted cardiac arrest.
Therefore the clinician must keep up with the most
recent information on Short QT Syndrome.
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